免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

NCT:NCT02438904 · RECRUITING

NCT编号NCT02438904
状态RECRUITING
开始日期2015-05-06
完成时间2027-05-01
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

简要摘要

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑